Yahoo · Nov 10, 2026
SOLV Q3 2026 deep dive: ERP transition, separation milestones, and margin focus define quarter
Healthcare solutions provider Solventum (NYSE:SOLV) reported Q3 2026 results topping the market’s revenue expectations, but sales fell by 7% year on year to $1.95 billion. Its non-GAAP profit of $1.45 per share was 7.9% above analysts’ consensus estimates.


